Cardiovascular Therapy

We have evaluated both the effectiveness and risk-stratification tools used to define the need for therapy in different populations

Therapeutic effectiveness

We pursued a series of comparative effectiveness studies spanning the synthesis of randomized clinical trials as well as observation comparative effectiveness in real-world data

JAMA Obesity.png

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events

JAMA. 2016;315(22):2424-2434

CovidACEInhibARB.jpg

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19

medRxiv. 2020 May 19:2020.05.17.20104943

WeightLossCardio.jpg

Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis

Gastroenterology. 2018 Apr;154(5):1309-1319.e7

USChinaHyper.png

Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study

BMJ. 2018 Jul 11;362:k2357

ACDRiskBMI.png

Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index

JAMA Netw Open. 2020 Oct 1;3(10):e2023242